BeOne Medicines (ONCN) Revenue
BeOne Medicines Revenue
BeOne Medicines had a revenue of 1.71B in the quarter ending Jun 30, 2026, with 12.66%. This bring the company's revenue in the last twelve months to 6.13B, Increased 6.79%. In the fiscal year ending Dec 31, 2025, BeOne Medicines had annual revenue of 5.34B with 40.23% growth.
- Revenue (ttm)
- 6.13B
- Revenue Growth
- 22.04%
- P/S Ratio
- 145.56
- Revenue/Employee
- MXN 445,253
- Employees
- 12,000
- Market Cap
- MXN 777.76B
Revenue Chart
BeOne Medicines Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.34B | 1.53B | 40.23% |
| Dec 31, 2024 | 3.81B | 1.35B | 54.96% |
| Dec 31, 2023 | 2.46B | 1.04B | 73.65% |
| Dec 31, 2022 | 1.42B | 239.64M | 20.37% |
| Dec 31, 2021 | 1.18B | 867.41M | 280.83% |
| Dec 31, 2020 | 308.87M | -119.34M | -27.87% |
| Dec 31, 2019 | 428.21M | 229.99M | 116.03% |
| Dec 31, 2018 | 198.22M | -40.17M | -16.85% |
| Dec 31, 2017 | 238.39M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.